KalVista Pharmaceuticals Switzerland GmbH

Pharmaceuticals · Zug, Zug

KalVista Pharmaceuticals Switzerland GmbH is a Swiss pharmaceuticals company based in Zug, Canton of Zug, listed in the Swiss commercial register since 2024 (UID CHE-476.260.624).

Legal nameKalVista Pharmaceuticals Switzerland GmbH
AddressBaarerstrasse, Zug
UID / VATCHE-476.260.624
Legal form · StatusGmbH · Active · 2024

Board members & signatories

  • Benjamin Palleiko — Geschäftsführer
  • KalVista Pharmaceuticals Limited (7543947) — Gesellschafter
  • Brian Krex

Registered purpose

Der Zweck der Gesellschaft ist die Entdeckung, Entwicklung und Vermarktung von pharmazeutischen Produkten. Die Gesellschaft kann lmmaterialgüterrechte erwerben, verwalten und übertragen. Die Gesellschaft kann Beteiligungen an Gesellschaften aller Art in der Schweiz und im Ausland erwerben, halten, verwalten und veräussern. Die Gesellschaft kann ausserdem alle Geschäfte tätigen und Vereinbarungen e…

🔒 Website🔒 Employees🔒 Revenue estimate

Source: Swiss commercial register (Zefix / SOGC) and Alpintel analysis · Data as of March 2026

What KalVista Pharmaceuticals Switzerland does

OFFERING

KalVista Pharmaceuticals focuses on developing orally-delivered small molecule medicines for the treatment of hereditary angioedema (HAE). Their primary product is an oral Factor XIIa inhibitor, which is designed to provide an on-demand treatment option for HAE patients.

Unlock the full analysis →

Similar companies

Find every pharmaceuticals company in Switzerland

Alpintel searches all 710,000 Swiss companies with AI — filter by industry, size, revenue, region and ownership in seconds.

family-owned pharmaceuticals companies with 50+ employees…Search →

Full profiles from CHF 49/month · Cancel anytime